Abstract |
The aim of this study was to evaluate whether emodin can overcome the chemoresistance of the gemcitabine-resistant cancer cell line (Bxpc-3/Gem) in vitro. The cell line Bxpc-3/Gem was derived from the human pancreatic cancer cell line Bxpc-3. We found that Bxpc-3/Gem cells were characterized by a series of morphological changes with a resistance index of 43.51 comparing with the parental cell line. Emodin reduced Bxpc-3/Gem cell proliferation in a dose-dependent manner. Emodin and gemcitabine combination treatments resulted in decreased cell proliferation and increased apoptosis in Bxpc-3/Gem cells. In addition, combination treatments resulted in downregulation of gene and protein expression of MDR-1 (P-gp), NF-κB, XIAP, survivin, as well as inhibition of NF-κB activity and P-gp function. These observations suggest that emodin may sensitize the pancreatic cancer gemcitabine-resistant cell line Bxpc-3/Gem to gemcitabine therapy via inhibition of survival signaling.
|
Authors | Wei Zhang, Hui Chen, Dian-Lei Liu, Hong Li, Jiang Luo, Jian-Hong Zhang, Ye Li, Kang-Jie Chen, Hong-Fei Tong, Sheng-Zhang Lin |
Journal | International journal of oncology
(Int J Oncol)
Vol. 42
Issue 4
Pg. 1189-96
(Apr 2013)
ISSN: 1791-2423 [Electronic] Greece |
PMID | 23440366
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Antimetabolites, Antineoplastic
- BIRC5 protein, human
- Inhibitor of Apoptosis Proteins
- NF-kappa B
- Survivin
- X-Linked Inhibitor of Apoptosis Protein
- XIAP protein, human
- Deoxycytidine
- CASP3 protein, human
- CASP9 protein, human
- Caspase 3
- Caspase 9
- Emodin
- Gemcitabine
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(genetics, metabolism)
- Antimetabolites, Antineoplastic
(pharmacology)
- Apoptosis
- Caspase 3
(genetics, metabolism)
- Caspase 9
(genetics, metabolism)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Shape
(drug effects)
- Deoxycytidine
(analogs & derivatives, pharmacology)
- Down-Regulation
- Drug Resistance, Neoplasm
(drug effects)
- Drug Synergism
- Emodin
(pharmacology)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Inhibitor of Apoptosis Proteins
(genetics, metabolism)
- Inhibitory Concentration 50
- NF-kappa B
(metabolism)
- Protein Binding
- Survivin
- X-Linked Inhibitor of Apoptosis Protein
(genetics, metabolism)
- Gemcitabine
|